Foresite into data

With a new $668 million fund, Foresite Capital is positioning itself to invest in more healthcare companies that use data science and machine learning in drug discovery and development, diagnostics, and patient identification and monitoring.

“In the next five to 10 years, we see a trend in companies becoming more inventive in ways they pool information. Computational methodologies are becoming more understood and applied, so we see an increase and growth of more current methods,” said Foresite CEO Jim Tananbaum. ...